Hemang Pandya, MD
Retina Specialist · Plano, TXNPI 1700100229
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $107,908 of the $153,126 with a category attached, or 70.5%. Novartis accounts for 67.1% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $107,850 and has fallen 96.6% since, to $3,656 in 2025. Among retina specialist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 274 payments — averaging $558.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$103K
- Astellas Pharma US Inc$18K
- Regeneron$8K
- Harrow Eye, LLC$3K
- Dutch Ophthalmic, USA$3K
- Alimera Sciences, Inc.$3K
- plus $15K from 25 others
Across 31 payments — averaging $1578.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$46K
- Boehringer Ingelheim International GmbH$2K
- Regeneron$1K
What the payments were for
- Consulting fees$21,63714%
- Speaking & faculty fees$107,90870%
- Travel & lodging$13,3669%
- Food & beverage$10,0657%
- Education$1280%
- Entertainment$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 93 | $102,774 |
| Astellas Pharma US Inc | 22 | $17,870 |
| Regeneron | 15 | $8,344 |
| Harrow Eye, LLC | 3 | $3,176 |
| Dutch Ophthalmic, USA | 10 | $3,137 |
| Alimera Sciences, Inc. | 8 | $2,977 |
| AbbVie(2 entities) | 27 | $2,947 |
| Thrombogenics, Inc. | 5 | $2,691 |
| GSK | 1 | $2,220 |
| Regeneron Healthcare Solutions, Inc. | 19 | $1,752 |
| Cardinal Health 108 LLC | 1 | $1,575 |
| Genentech USA, Inc. | 21 | $834 |
| Notal Vision, Inc. | 4 | $618 |
| Eyepoint US, Inc. | 7 | $407 |
| Bausch & Lomb Americas Inc. | 4 | $250 |
| Apellis Pharmaceuticals, Inc. | 5 | $239 |
| Mallinckrodt Hospital Products Inc. | 2 | $213 |
| Coherus Oncology, Inc. | 3 | $192 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $176 |
| Genentech, Inc. | 3 | $147 |
| Astellas Pharma Global Development | 2 | $111 |
| Topcon Healthcare, Inc. | 3 | $103 |
| Carl Zeiss Meditec, Inc. | 2 | $102 |
| Biotissue Holdings Inc. | 4 | $87 |
| Ivantis, Inc | 1 | $38 |
| Optos, Inc. | 2 | $34 |
| Mallinckrodt Enterprises LLC | 1 | $29 |
| Heidelberg Engineering, Inc. | 1 | $26 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Kala Pharmaceuticals, Inc. | 1 | $21 |
| Spark Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$153,126 in reported general payments places this provider in the 90th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 81 | $3,532 |
| MoxifloxacinMoxifloxacin Hcl | 56 | $1,055 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 47 | $688 |
| Ketorolac Tromethamine | 29 | $361 |
| Latanoprost | 20 | $175 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Plano
- Matthew AdamsPlano$31K
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Judy KimDallas$256K
- Emmanuel ChangBellaire$254K
- Ting Fang SuarezBellaire$156K
- Margaret RunnerSouthlake$71K
- Moises ChicaSan Antonio$43K
- Garvin DavisHouston$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.